
How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?
How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?
What toll does trauma take on police officers, firefighters, and EMT workers?
What are the risk factors for and prevalence overweight and obesity in patients with first-episode drug-naïve major depressive disorder?
A clinical review of an effective approach for treatment-resistant depression.
What will psychiatric practice look like in the year 2030?
Could the emerging field of epigenetics hold the key to catching postpartum depression before it happens?
What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.
Blue light is associated with a host of physical health maladies, including obesity, diabetes, and cancer. But what does it do to patients with depression or bipolar disorder?
A deep dive into the history, side effects, and efficacy of a controversial drug.
A rare robust finding from a study on bipolar depression.
If approved, SLS-002 would be only the second approved product for ASIB.
Apathy occurs throughout the spectrum of neurocognitive disorders, but it is easy to mistake for other conditions, like depression. How can clinicians identify apathy, and treat it?
Research confirms COVID-19’s negative impact on Americans’ mental health.
Travelling the middle road between skepticism and scientism in psychiatric research and treatment.
Although depression is more prevalent among women, it may be more challenging to diagnose in men. This National Men’s Health Month, learn to recognize male depression’s symptoms and catch its comorbidities.
Is depression the same today as it was in the 17th century? Is it the same thing in Nigeria as it is in the United States? One of the foremost historians of psychiatry weighs in.
A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.
Health outcomes are often determined by factors outside of the hospital and clinic. How can psychiatrists address mental health challenges before they become emergencies?
Medical aid in dying is available for psychiatric patients in European countries and Canada. Will the United States be next?
Being unable to experience pleasure and having difficulty imagining future enjoyment are different problems—and may require different treatments.
A Psychiatric Times point/counterpoint feature on electroconvulsive therapy elicited strong responses.
Research data shows that ECT is often more effective than alternative treatments, and safe too.
ECT has been in use for decades, but does that mean it is safe or effective?
Will a new Canadian law overturn long-held ethical norms in psychiatry?